Curis Inc (CRIS)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | RUBIN, MARC | Director | Non Qualified Stock Option | Acquisition | 6,800 | $5.29 |
| Jul 7, 2026 | BORGMAN, ANNE ELIZABETH | Director | Non Qualified Stock Option | Acquisition | 6,800 | $5.29 |
| Jul 7, 2026 | GREENACRE, MARTYN D | Director | Non Qualified Stock Option | Acquisition | 6,800 | $5.29 |
| Jul 7, 2026 | DENTZER, JAMES E | Director, President & CEO | Employee stock option (right to buy) | Acquisition | 110,090 | $5.29 |
| Jul 7, 2026 | HOHNEKER, JOHN | Director | Non Qualified Stock Option | Acquisition | 6,800 | $5.29 |
| Jul 7, 2026 | ZUNG, JONATHAN B. | CDO | Employee stock option (right to buy) | Acquisition | 48,285 | $5.29 |
| Jul 7, 2026 | KAITIN, KENNETH I | Director | Non Qualified Stock Option | Acquisition | 6,800 | $5.29 |
| Jul 7, 2026 | DUVALL, DIANTHA | CFO | Employee stock option (right to buy) | Acquisition | 48,285 | $5.29 |
| Mar 31, 2026 | KAITIN, KENNETH I | Director | Common Stock | Acquisition | 10,000 | $0.55 |
| Mar 20, 2026 | DENTZER, JAMES E | Director, President & CEO | Common Stock | Acquisition | 133,333 | n/a |
| Mar 20, 2026 | DUVALL, DIANTHA | CFO | Common Stock | Acquisition | 66,666 | n/a |
| Mar 20, 2026 | ZUNG, JONATHAN B. | CDO | Common Stock | Acquisition | 66,667 | n/a |
| Mar 20, 2026 | DUVALL, DIANTHA | CFO | Series B Convertible Preferred Stock | Disposal | 50 | n/a |
| Mar 20, 2026 | DENTZER, JAMES E | Director, President & CEO | Series B Convertible Preferred Stock | Disposal | 100 | n/a |
| Mar 20, 2026 | ZUNG, JONATHAN B. | CDO | Series B Convertible Preferred Stock | Disposal | 50 | n/a |
| Mar 20, 2026 | HAMDY, AHMED MD | CMO | Series B Convertible Preferred Stock | Disposal | 50 | n/a |
| Mar 20, 2026 | RUBIN, MARC | Director | Series B Convertible Preferred Stock | Disposal | 20 | n/a |
| Mar 20, 2026 | RUBIN, MARC | Director | Common Stock | Acquisition | 26,667 | n/a |
| Mar 20, 2026 | HAMDY, AHMED MD | CMO | Common Stock | Acquisition | 66,667 | n/a |
| Mar 20, 2026 | DUVALL, DIANTHA | CFO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 20, 2026 | ZUNG, JONATHAN B. | CDO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 20, 2026 | HAMDY, AHMED MD | CMO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 20, 2026 | DENTZER, JAMES E | Director, President & CEO | Series B Convertible Preferred Stock | Acquisition | 100 | n/a |
| Mar 20, 2026 | RUBIN, MARC | Director | Series B Convertible Preferred Stock | Acquisition | 20 | n/a |
| Mar 17, 2026 | DUVALL, DIANTHA | CFO | Series B Warrant (right to buy) | Acquisition | 66,666 | n/a |
| Mar 17, 2026 | RUBIN, MARC | Director | Series C Warrant (right to buy) | Acquisition | 26,667 | n/a |
| Mar 17, 2026 | DENTZER, JAMES E | Director, President & CEO | Series A Warrant (right to buy) | Acquisition | 133,333 | n/a |
| Mar 17, 2026 | ZUNG, JONATHAN B. | CDO | Series B Warrant (right to buy) | Acquisition | 66,667 | n/a |
| Mar 17, 2026 | HAMDY, AHMED MD | CMO | Series A Warrant (right to buy) | Acquisition | 66,667 | n/a |
| Mar 17, 2026 | HAMDY, AHMED MD | CMO | Series B Warrant (right to buy) | Acquisition | 66,667 | n/a |
| Mar 17, 2026 | ZUNG, JONATHAN B. | CDO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 17, 2026 | DENTZER, JAMES E | Director, President & CEO | Series B Warrant (right to buy) | Acquisition | 133,333 | n/a |
| Mar 17, 2026 | ZUNG, JONATHAN B. | CDO | Series A Warrant (right to buy) | Acquisition | 66,667 | n/a |
| Mar 17, 2026 | RUBIN, MARC | Director | Series A Warrant (right to buy) | Acquisition | 26,667 | n/a |
| Mar 17, 2026 | DUVALL, DIANTHA | CFO | Series A Warrant (right to buy) | Acquisition | 66,666 | n/a |
| Mar 17, 2026 | DENTZER, JAMES E | Director, President & CEO | Series B Convertible Preferred Stock | Acquisition | 100 | n/a |
| Mar 17, 2026 | RUBIN, MARC | Director | Series B Convertible Preferred Stock | Acquisition | 20 | n/a |
| Mar 17, 2026 | HAMDY, AHMED MD | CMO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 17, 2026 | DUVALL, DIANTHA | CFO | Series B Convertible Preferred Stock | Acquisition | 50 | n/a |
| Mar 17, 2026 | DUVALL, DIANTHA | CFO | Series C Warrant (right to buy) | Acquisition | 66,666 | n/a |
| Mar 17, 2026 | DENTZER, JAMES E | Director, President & CEO | Series C Warrant (right to buy) | Acquisition | 133,333 | n/a |
| Mar 17, 2026 | ZUNG, JONATHAN B. | CDO | Series C Warrant (right to buy) | Acquisition | 66,667 | n/a |
| Mar 17, 2026 | RUBIN, MARC | Director | Series B Warrant (right to buy) | Acquisition | 26,667 | n/a |
| Mar 17, 2026 | HAMDY, AHMED MD | CMO | Series C Warrant (right to buy) | Acquisition | 66,667 | n/a |